Lotemax Patent Expires Today

Quote












Think about trying to sell loto gel to lasik accts. They hate besi for lasik bc of flap displacement. They thought the HARD job was selling the two brand NEW drugs on mkt. Anti inflammatory is the toughest sell.good thingnew products coming. Glaucoma back of the eye compteting w prostaglandin should b revolutionary.....just hope there is no BAK
 






You're not going to do anything with glaucoma.

Xalatan generic will crush you dead in your tracks. plus the other monkeys out trying to scratch whatever piece of business they can buy off to try and keep.

Glaucoma docs are not early adopters. They want 5 to 10 year data before they do anything new and they want big studies. Massive. As they say in hockey, you've got "no stick"

have fun with another B&L product launch DUD!
 






Anonymous said:
You're not going to do anything with glaucoma.

Xalatan generic will crush you dead in your tracks. plus the other monkeys out trying to scratch whatever piece of business they can buy off to try and keep.

Glaucoma docs are not early adopters. They want 5 to 10 year data before they do anything new and they want big studies. Massive. As they say in hockey, you've got "no stick"

have fun with another B&L product launch DUD!
Click to expand...

Sounds like a scared competitor, see many of us know about glaucoma what about zioptan, combigan, if our works entirely different in moa docs will use it. Go away scared Alvin, Allergan rep
 












Anonymous said:
Sounds like a scared competitor, see many of us know about glaucoma what about zioptan, combigan, if our works entirely different in moa docs will use it. Go away scared Alvin, Allergan rep
Click to expand...

you're an idiot. you will be lucky to even still have a job if and when that product ever comes to market. just completed phase 2. you have years before that product comes out, if ever.

formulary access. B&L's Achilles heel. maybe this time around they will plan to have it available on major plans at tier 2. With xalatan going generic and other generic drops, or other products with tier 2 access it is all formulary driven now. reps have very little real impact.

you're going to sit around saying wait till we have this. You'll wait 3 years for the product just like you did with besivance and 6 months after the launch, if you're lucky, it will still just be the same old B&L. by that time it could be pfizer and you'll all be gone.
 






I just had to pay $200 fo 10ml! With insurance and discount card it was still $150. I have cornea transplant and I'm not about to risk them to Indian knockoffs. The patent is said to expire Oct. 23, 2013. Can't believe there won't be a generic at that price. Last year 10ml was $40 an I thought THAT was outrageous.
 












Anonymous said:
I just had to pay $200 fo 10ml! With insurance and discount card it was still $150. I have cornea transplant and I'm not about to risk them to Indian knockoffs. The patent is said to expire Oct. 23, 2013. Can't believe there won't be a generic at that price. Last year 10ml was $40 an I thought THAT was outrageous.
Click to expand...

You think $40 is a lot to save your eyesight? Get a life, maybe you should reevaluate your priories. As far as having insurance suspension is covered EVERYWHERE you'd be hard pressed to find a plan it's not covered on... So I'm going to call bullshit.
 


















Top Bottom
Back
Quote